BioSpace News Archive

Genetown

PureTech Announces Share Buyback Program of up to $50 Million

PureTech Health plc announces that its Board of Directors has approved a share buyback program in respect of its ordinary shares of one pence each up to a maximum consideration of $50 million.

May 5, 2022
·
4 min read
Biotech Bay

Annexon Biosciences to Participate in Upcoming May 2022 Investor Conferences

Annexon, Inc. announced that Douglas Love, Esq., president & chief executive officer, will participate in fireside chats during the following May investor conferences:

May 5, 2022
·
1 min read
Deals

Caris’ Precision Oncology Alliance Welcomes Loma Linda University Cancer Center

Caris Life Sciences® announced today that Loma Linda University Cancer Center (LLU Cancer Center) has joined Caris’ Precision Oncology Alliance™ (POA).

May 5, 2022
·
5 min read
Business

Aeglea BioTherapeutics Reports First Quarter 2022 Financial Results and Provides Program Updates

Aeglea BioTherapeutics, Inc. announced financial results for the first quarter 2022 and provided program updates.

May 5, 2022
·
11 min read
Business

BD Reports Second Quarter Fiscal 2022 Financial Results

BD, a leading global medical technology company, announced results for its second quarter of fiscal year 2022, which ended March 31, 2022.

May 5, 2022
·
38 min read
Business

InfuSystem Reports First Quarter 2022 Financial Results

InfuSystem Holdings, Inc., a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, reported financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
21 min read
Business

Cardinal Health Reports Third Quarter Fiscal 2022 Results

Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2022 revenues of $44.8 billion, an increase of 14% from the third quarter of last year.

May 5, 2022
·
40 min read
Business

Matinas BioPharma to Webcast Conference Call Discussing First Quarter 2022 Financial and Operational Results on May 12, 2022

Matinas BioPharma Holdings, Inc. today announced the Company will host a conference call and live audio webcast on Thursday, May 12, 2022 at 8:30 a.m. ET to discuss operational and financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
4 min read
Pharm Country

Nabriva Extends Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S. Through the End of 2026

Nabriva Therapeutics plc announced that it agreed to an extension of its exclusive agreement with subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA, known as MSD outside the United States and Canada, to promote and distribute SIVEXTRO® in the United States through December 31, 2026.

May 5, 2022
·
7 min read
Lone Star Bio

Vaxxinity to Participate at the Bank of America Securities 2022 Healthcare Conference

Vaxxinity, Inc. announced that Mei Mei Hu, President and Chief Executive Officer of Vaxxinity, will participate in a fireside chat at the Bank of America Securities 2022 Healthcare Conference, being held in Las Vegas, Nevada on Thursday, May 12, 2022 at 10:40 a.m. PT.

May 5, 2022
·
2 min read